MEZZETTI, Andrea
 Distribuzione geografica
Continente #
NA - Nord America 15.179
EU - Europa 11.505
AS - Asia 10.200
SA - Sud America 1.020
AF - Africa 143
Continente sconosciuto - Info sul continente non disponibili 18
OC - Oceania 14
Totale 38.079
Nazione #
US - Stati Uniti d'America 14.882
SG - Singapore 3.882
CN - Cina 2.964
UA - Ucraina 1.773
RU - Federazione Russa 1.755
IT - Italia 1.494
IE - Irlanda 1.424
TR - Turchia 1.349
GB - Regno Unito 1.237
SE - Svezia 1.165
DE - Germania 951
FR - Francia 917
BR - Brasile 850
VN - Vietnam 803
IN - India 555
FI - Finlandia 476
CA - Canada 168
BD - Bangladesh 148
HK - Hong Kong 110
MX - Messico 91
PL - Polonia 80
AR - Argentina 68
JP - Giappone 66
IQ - Iraq 52
ZA - Sudafrica 51
ES - Italia 48
NL - Olanda 38
KR - Corea 35
ID - Indonesia 34
PK - Pakistan 33
BE - Belgio 30
CZ - Repubblica Ceca 29
EC - Ecuador 28
IL - Israele 26
MA - Marocco 23
IR - Iran 21
CO - Colombia 20
LT - Lituania 18
UZ - Uzbekistan 18
AT - Austria 17
EU - Europa 16
SA - Arabia Saudita 16
VE - Venezuela 16
EG - Egitto 14
KE - Kenya 14
MY - Malesia 14
PY - Paraguay 12
AE - Emirati Arabi Uniti 9
AU - Australia 9
JO - Giordania 9
PH - Filippine 9
TN - Tunisia 9
UY - Uruguay 9
DZ - Algeria 8
GR - Grecia 8
RO - Romania 8
CL - Cile 7
CR - Costa Rica 7
AZ - Azerbaigian 6
ET - Etiopia 6
PE - Perù 6
AL - Albania 5
CH - Svizzera 5
HN - Honduras 5
AO - Angola 4
BH - Bahrain 4
CI - Costa d'Avorio 4
DK - Danimarca 4
JM - Giamaica 4
KZ - Kazakistan 4
NO - Norvegia 4
NP - Nepal 4
NZ - Nuova Zelanda 4
OM - Oman 4
PS - Palestinian Territory 4
TT - Trinidad e Tobago 4
TW - Taiwan 4
BG - Bulgaria 3
GT - Guatemala 3
MD - Moldavia 3
NI - Nicaragua 3
RS - Serbia 3
SN - Senegal 3
SY - Repubblica araba siriana 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BB - Barbados 2
BO - Bolivia 2
BY - Bielorussia 2
DO - Repubblica Dominicana 2
GE - Georgia 2
HU - Ungheria 2
MN - Mongolia 2
MU - Mauritius 2
PA - Panama 2
PT - Portogallo 2
SR - Suriname 2
SV - El Salvador 2
AM - Armenia 1
BN - Brunei Darussalam 1
BS - Bahamas 1
Totale 38.058
Città #
Singapore 2.818
Jacksonville 1.945
San Jose 1.789
Chandler 1.722
Dublin 1.409
Ashburn 932
Southend 886
Izmir 728
Princeton 675
Beijing 656
Dallas 544
Nanjing 533
Dearborn 406
Los Angeles 392
Wilmington 381
Munich 345
Council Bluffs 344
Cambridge 323
The Dalles 323
New York 306
Ho Chi Minh City 287
Tongling 258
Santa Clara 249
Nanchang 214
Ann Arbor 184
Buffalo 171
Hanoi 154
Chieti 153
Altamura 151
Moscow 150
Woodbridge 148
Helsinki 118
Shenyang 116
Boardman 113
São Paulo 104
Hebei 99
Hong Kong 94
Houston 93
Tianjin 90
Milan 86
Rome 76
Washington 73
Jiaxing 72
Montreal 69
Grevenbroich 66
Brooklyn 65
Warsaw 65
Denver 56
Kunming 55
Tokyo 55
Orem 54
Changsha 51
Chennai 50
Hefei 50
Pescara 48
Jinan 47
Stockholm 46
Toronto 46
Hangzhou 44
Da Nang 42
Redondo Beach 42
Atlanta 40
Rio de Janeiro 40
Johannesburg 39
Chicago 38
Haiphong 38
Norwalk 38
San Mateo 38
London 37
Poplar 36
Seattle 36
Orange 35
Mexico City 34
Seoul 33
Phoenix 32
Frankfurt am Main 31
Manchester 31
Auburn Hills 30
Guangzhou 30
Zhengzhou 29
Augusta 28
Brussels 28
Boston 27
Ningbo 27
Brno 24
Lanzhou 24
Turku 24
Changchun 22
Mumbai 21
Baghdad 20
Curitiba 20
San Francisco 20
Taizhou 19
Belo Horizonte 18
Biên Hòa 18
Querétaro 18
Falls Church 17
Leawood 17
Amsterdam 16
Hải Dương 16
Totale 22.750
Nome #
Vascular characteristic in hypertensive patients with different left ventricular morphology 788
Indici di rigidità arteriosa e rischio cardiovascolare globale: risultati da una popolazione abruzzese in prevenzione primaria 553
Rimodellamento concentrico del ventricolo sx in pazienti con ipertensione essenziale: è un pattern geometrico omogeneo? 268
Rosuvastatin reduces Matrix Metalloproteinase (MMP)-9 and Plasminogen Activator Inhibitor (PAI)-1 expression via a microRNA-dependent pathway 253
MicroRNA profiling in migraine without aura: Pilot study 253
Ouabaina endogena, pattern emodinamico e geometria ventricolare sx nell'ipertensione essenziale. 220
A unique microRNA signature associated with plaque instability in humans. 209
Vitamin E supplementation normalizes LDL susceptibility to oxidation in well controlled uncomplicated type II diabetes mellitus 203
(Dis)-agreement among Cardiovascular Risk Calculators in clinical practice 183
Bioequivalence study of two capsule formulations of omeprazole in healthy volunteers 179
Ossidazione delle LDL e vitamine antiossidanti in pazienti ipertesi dipper e nondipper. 176
A prothrombotic state 176
Suppression of RAGE as a basis of simvastatin-dependent plaque stabilization in type 2 diabetes. 174
Increased expression of transforming growth factor-beta1 as a stabilizing factor in human atherosclerotic plaques. 173
Blood cardioplegia: could it protect the ischemic-reperfused human myocardium through antioxidant-type mechanisms? 168
Multicentric cohort study on the long-term efficacy and safety of electronic cigarettes: Study design and methodology 167
Blockade of the angiotensin II type 1 receptor stabilizes atherosclerotic plaques in humans by inhibiting prostaglandin E2-dependent matrix metalloproteases activity 166
Differences in blood pressure according to body position (supine, Fowler’s and sitting) in hypertensive subjects 165
Bioequivalence study of two tablet formulations of ramipril in healthy volunteers 163
'White-coat' hypertension in patients with newly diagnosed hypertension: evaluation of prevalence by ambulatory monitoring and impact on cost of health care 163
OVEREXPRESSION OF TOLL LIKE RECEPTOR 4 AS A BASIS OF CYCLOOXYGENASE 2-DEPENDENT ATHEROSCLEROTIC PLAQUE INSTABILITY IN HUMANS. 160
Elevated circulating levels of monocyte chemoattractant protein-1 in patients with restenosis after coronary angioplasty. 159
Il trattamento con Metformina riduce i livelli di alcuni indicatori di stress ossidativi in diabetici di tipo 2 158
Necrotizing fasciitis caused by Pseudomonas Aeruginosa 157
Low density lipoprotein oxidation and antioxidant vitamins in dipper and nondipper hypertensive patients 156
A unique microRNA signature associated with ischemic stroke in humans 155
Plasma exosome microRNA profiling unravels a new potential modulator of adiponectin pathway in diabetes: effect of glycemic control 155
Cardiovascular risk in patients receiving double therapy with false and true nonresponder hypertension. 154
EGFR mutations in non-small-cell lung cancer: analysis of a large series of cases and development of a rapid and sensitive method for diagnostic screening with potential implications on pharmacologic treatment. 153
White-coat resistant hypertension 153
Low density lipoprotein oxidation in white coat and sustained hypertension (pubbl. su Am J Hypertension). 152
Overexpression of microRNA-145 in atherosclerotic plaques from hypertensive patients 152
Additional Antihypertensive effect of fluvastatin in hypertensive and hypercholesterolemic patients treated with trandolapril. 151
A 31P-Nuclear magnetic resonance study of intermittent warm blood cardioplegia 151
A Polymorphism in the Cyclooxygenase 2 Gene as an Inherited Protective Factor Against Myocardial Infarction and Stroke 151
Thromboxane-dependent CD40 ligand release in type 2 diabetes mellitus 151
Preprocedural level of soluble CD40L is predictive of enhanced inflammatory response and restenosis after coronary angioplasty. 151
Use of Contrast-enhanced ultrasound (CEUS) in systemic mastocytosis. Report of two cases 150
Lower rate of cardiovascular complications in patients on bolus insulin analogues: a retrospective population-based cohort study 150
Association between prostaglandin E receptor subtype EP4 overexpression and unstable phenotype in atherosclerotic plaques in human. 148
Relationship between oxidative stress, monocyte activation and restenosis after coronary angioplasty. 147
Angiotensin-converting enzyme inhibitors counteract hypoxia-induced coronary constriction in the isolated rat heart 147
Sarcoidosis: Old certainties and new perspectives [La sarcoidosi: Vecchie certezze e nuove prospettive] 147
Attività della paraoxonasi sierica in pazienti con ipertensione arteriosa essenziale. 146
Aortic glutathione-related antioxidant defences in rabbits subjected to suprarenal aortic coarctation hypertension 145
[Controllo dei fattori di rischio cardiovascolare nella comune pratica clinica in un campione di pazienti in prevenzione secondaria rappresentativo della popolazione abruzzese] 144
Angiotensin II Blockade and Total Cardiovascular Risk. Beyond Blood Pressure Reduction. 143
Cephalosporins are scavengers of hypochlorous acid 143
Ipertensione arteriosa ed algosensibilità muscolare 143
MicroRNA profiling reveals new potential modulators of insulin-resistance and cardiovascular risk in type 2 diabetes 143
New insights into the cardiovascular risk of migraine and the role of white matter hyperintensities: is gold all that glitters? 143
Efficacy of a nurse-led email reminder program for cardiovascular prevention risk reduction in hypertensive patients: a randomized controlled trial. 142
Circadian variations in antioxidant defences and lipid peroxidation in the rat heart 141
Effect of Rosuvastatin on ABCA1 and ABCG1 expression in human atherosclerotic plaques: results from the QUASAR study 141
Guidelines enforcement and clinical outcome 141
Contribution of myofascial trigger points to migraine symptoms 141
Blunted nocturnal fall in blood pressure and oxidative stress in men and women with essential hypertension. 140
ABCA-1 expression is reduced in atherosclerotic plaques from hypertensive patients: a new potential link between hypertension and atherosclerosis 140
Effect of Rosuvastatin on MicroRNAs expression in human atherosclerotic plaques: results from Quasar Study 140
Transmural distribution of antioxidant defences and lipid peroxidation in the rabbit left ventricular myocardium 139
ATP-binding cassette transporter A1 (ABCA1) overexpression in hypercholesterolemic plaques: a potential molecular explanation 139
Cigarette smoke, ferritin, and lipid peroxidation 139
Blood cardioplegia reduces oxidant burden in the ischemic and reperfused human myocardium 139
Mutational analysis of the HER2 gene in lung tumors from Caucasian patients: mutations are mainly present in adenocarcinomas with bronchioloalveolar features. 138
Int6 expression can predict survival in early-stage non-small cell lung cancer patients. 138
Cardiovascular outcome in treated hypertensive patients with responder, masked, false resistant, and true resistant hypertension. 138
Effects of vitamin E supplementation on intracellular antioxidant enzyme production in adolescents with type 1 diabetes and early microangiopathy. 137
Antioxidant metabolic mechanisms in hypertensive and atherosclerotic arterial wall 137
Association between 5-lipoxygenase expression and plaque instability in humans. 135
Effects of vitamin E supplementation on F2-isoprostane and thromboxane biosynthesis in healthy cigarette smokers. 134
Heightened free radical activity in angina pectoris 134
Overexpression of ABCA1 in human plaques exposed to hypercholesterolemia: the role of microRNA modulation 134
Effects of irbesartan on intracellular antioxidant enzyme expression and activity in adolescents and young adults with early diabetic angiopathy 134
Aortic antioxidant defence mechanisms during the progression of atherosclerosis in cholesterol-fed rabbits 134
Paraoxonase activity is significantly reduced in smokers. Effect of vitamin E supplementation 133
Effect of ischemia and reperfusion on antioxidant enzymes and mitochondrial inner membrane proteins in perfused rat heart. 133
High preprocedural non-HDL cholesterol is associated with enhanced oxidative stress and monocyte activation after coronary angioplasty: possible implications in restenosis. 133
Effect of 2-year treatment with low-dose rosuvastatin on intima-media thickness in hypercholesterolemic subjects with asymptomatic carotid artery disease 133
MicroRNA profiling reveals new potential modulators of insulin-resistance in type 2 Diabetes 133
Low-density lipoprotein oxidation and vitamins E and C in sustained and white-coat hypertension. 132
La Sindrome Miofasciale come fattore di attivazione della sintomatologia dolorosa della Fibromialgia 131
Advanced glycation end products in adolescents and young adults with diabetic angiopathy. 130
(In)accuracy of blood pressure measurement in 14 Italian hospitals 130
ABCA-1 Expression is reduced in atherosclerotic plaques of hypertensive patient: a new link between hypertension and atherosclerosis 130
Blood pressure variability and cardiovascular risk in treated hypertensive patients. 130
[Physiopathological bases of the medical treatment of portal hypertension]. 129
The black esophagus 129
Distribuzione transmurale dei sistemi antiossidanti e della perossidazione lipidica nel ventricolo sinistro di coniglio 129
Vitamin E inhibits enhanced F2 isoprostane biosynthesis in type IIA hypercholesterolemia 128
Overexpression of functionally coupled cyclooxygenase-2 and prostaglandin E synthase in symptomatic atherosclerotic plaques as a basis of prostaglandin E(2)-dependent plaque instability. 128
LDL-Apheresis abruzzo network: an old-new opportunity for the management of patients at high cardiovascular risk. 128
La gestione del profilo lipidico nei pazienti in prevenzione secondaria sul territorio: lo studio ELL 128
The (K+)ey of the problem 128
Relationship between reduced BCL-2 expression in circulating mononuclear cells and early nephropathy in type 1 diabetes. 127
Glutathione-related enzyme activities and lipoperoxide levels in human internal mammary artery and ascending aorta. Relations with serum lipids 127
[The role of hypothermia and of potassium-induced cardioplegia in the protection of the ischemic myocardium during aortopulmonary bypass]. 127
Ambulatory blood pressure stage 126
Arterial disease in dipper and nondipper hypertensive patients. 126
Heparin: does it act as an antioxidant in vivo? 126
Viscero-visceral hyperalgesia: characterization in different clinical models 126
Totale 15.993
Categoria #
all - tutte 142.874
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 142.874


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202187 0 0 0 0 0 0 0 0 0 0 0 87
2021/20221.420 33 27 14 304 145 19 23 101 113 41 175 425
2022/20234.677 357 617 246 541 433 977 292 325 605 63 123 98
2023/20242.193 169 74 153 64 117 698 514 60 25 71 15 233
2024/20255.404 320 851 709 72 154 215 196 253 542 239 698 1.155
2025/202611.873 1.017 417 1.028 1.475 1.125 755 1.932 659 1.804 929 628 104
Totale 38.530